Search results
Fact check: Trump falsely claims Biden didn’t lower Americans’ insulin costs | CNN Politics
CNN.com· 7 days agoPresident Joe Biden is campaigning on his success in getting seniors with diabetes a $35-per-month...
Older Americans worry they can’t afford their own health care | CNN
CNN.com· 3 days agoWhat weighs most heavily on older adults’ minds when it comes to health care? “It’s on our minds a...
Kirsten Axelsen: Affordable access to weight loss drugs needed (Opinion)
The Charleston Gazette· 1 day agoSen. Bernie Sanders, I-Vt., is getting a piece of the attention being paid to weight loss drugs. Unsurprisingly, these medicines have gotten a lot of notice; losing weight and keeping it off ...
Amazon Pharmacy Targets Medicare Population
Forbes· 3 days agoMillions of seniors who are 65 and older tend to have drug coverage if they purchase privatized health insurance known as Medicare Advantage or a...
RI hospitals may soon be required by state law to disclose price of services. Here's how
The Providence Journal via Yahoo News· 2 days agoUnder de la Cruz’s legislation, hospitals not complying with the transparency requirement would be...
Lantheus (LNTH) Gains 33.3% YTD: What's Driving the Stock?
Zacks· 3 days agoFree Report) witnessed strong momentum in the year-to-date period. Shares of the company have rallied 33.3% compared with 3.1% growth of the industry. With healthy fundamentals ...
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
CNBC· 4 days agoSkyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new...
Fact check: Trump falsely claims Biden didn’t lower Americans’ insulin costs
WKBT La Crosse· 7 days agoPresident Joe Biden is campaigning on his success in getting seniors with diabetes a $35-per-month cap on their insulin spending. Facts First: Trump’s claims that Biden did nothing to lower ...
Gateway - Quartz
Quartz· 3 days agoCenters for Medicare and Medicaid Services (CMS) announced on Thursday. “CMS has issued guidance to Medicare Part D
Gateway - Quartz
Quartz· 3 days agoAfter dominating the market for weight loss drugs, Ozempic maker Novo Nordisk has set its sights on tackling treatments for heart disease next. Cardior, a Germany-based drug maker, develops ...